Collegium Pharmaceutical Inc

NASDAQ:COLL   3:59:58 PM EDT
19.13
+0.26 (+1.35%)
Products, Litigation

Collegium Announces Settlement With Teva Resolving Xtampza Er Patent Litigation

Published: 09/30/2020 12:37 GMT
Collegium Pharmaceutical Inc (COLL) - Collegium Announces Settlement With Teva Resolving Xtampza Er Patent Litigation.
Collegium - Reached a Settlement Agreement With Teva Pharmaceutical USA.
Collegium - Will Grant Teva a License to Market Its Generic Version of Xtampza Er in the United States Beginning on Or After September 2, 2033.
Collegium - Teva Agreed to Consent Judgment Confirming Its Proposed Generic Products Infringe Co's Asserted Patents & That Those Patents Are Valid.
Collegium - Additional Details Regarding the Settlement Are Confidential.